1. Home
  2. RELY vs SYRE Comparison

RELY vs SYRE Comparison

Compare RELY & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Remitly Global Inc.

RELY

Remitly Global Inc.

HOLD

Current Price

$13.77

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELY
SYRE
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
RELY
SYRE
Price
$13.77
$33.30
Analyst Decision
Buy
Strong Buy
Analyst Count
10
6
Target Price
$26.00
$56.50
AVG Volume (30 Days)
2.5M
795.0K
Earning Date
02-18-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,544,865,000.00
N/A
Revenue This Year
$30.78
N/A
Revenue Next Year
$18.57
N/A
P/E Ratio
$145.89
N/A
Revenue Growth
31.27
N/A
52 Week Low
$12.08
$10.91
52 Week High
$27.32
$35.31

Technical Indicators

Market Signals
Indicator
RELY
SYRE
Relative Strength Index (RSI) 49.60 58.08
Support Level $13.06 $30.00
Resistance Level $13.88 $34.21
Average True Range (ATR) 0.41 1.83
MACD 0.00 -0.02
Stochastic Oscillator 55.07 84.46

Price Performance

Historical Comparison
RELY
SYRE

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: